Stock Quote
EXACT Sciences Corporation (EXAS.W) (NASD ADF)
$2.73
11 Nov 2009
+3.80%
$2.63
$2.72
200
$2.73
$2.72
$3.15
$0.22
1.50
41,080
EXAS.W
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Zenner, Patrick | Chairman of the Board | 32,267 |
| Conroy, Kevin | President,Chief Executive Officer,Director | -- |
| Arora, Maneesh | Chief Financial Officer, Senior Vice President | -- |
Profile
EXACT Sciences Corporation develops deoxyribonucleic acid (DNA)-based technologies for use in the detection of cancer. The Company has selected colorectal cancer as the first application of its technologies. The Company has licensed certain of its technologies, on an exclusive basis through December... Full Description
Company Address
EXACT Sciences Corporation
100 Campus Drive
Marlborough MA 01752
P: +1508.6831200
F: +1508.6831201
100 Campus Drive
Marlborough MA 01752
P: +1508.6831200
F: +1508.6831201
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| NorDiag ASA | kr4.33 | +0.21 |
| Immunomedics, Inc. | $3.53 | -0.04 |
| ImmunoGen, Inc. | $8.53 | +0.18 |
| EXAS.W | Industry | |
|---|---|---|
| P/E(TTM) | -- | 12.80 |
| P/S(TTM) | 27.07 | 29.90 |
| ROI(TTM) | -86.07 | 2.35 |
| ROE(TTM) | -278.34 | 3.59 |
No consensus estimates data available.
| Total Revenue | $1.26M |
| Net Income | $-1.04M |
| EPS | $-0.03 |
